当前位置:公众访问 >页面
简体中文 / English
集成血液净化治疗模式对CCL14识别的持续性SA-AKI风险患者的疗效评估

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR2400093572

研究题目:

集成血液净化治疗模式对CCL14识别的持续性SA-AKI风险患者的疗效评估

Study title:

Efficacy of hybrid blood purification for SA-AKI subtypes identified by CCL14

 注册状况:

 Registration:

True

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

郑瑞强

Corresponding person:

Ruiqiang Zheng

电话:

Telephone:

18205257081

电子邮件

Email

skrhero0313@126.com

通讯地址:

扬州大学附属苏北人民医院

Address:

Northern Jiangsu People's Hospital Affiliated to Yangzhou University

邮政编码

Postcode

225000

项目负责人所有单位:

扬州大学附属苏北人民医院

Institution:

Northern Jiangsu People's Hospital Affiliated to Y

批准本研究的伦理委员会名称:

苏北人民医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Northern Jiangsu Peopl

研究疾病:

脓毒症相关急性肾损伤

Study Ailment:

Sepsis associated Acute Kidney Injury

研究所处阶段:

Study phase:

上市后

研究类型:

Type of Study:

诊断准确性试验

研究团队:

於江泉、蒋伟、史科然、王海霞、赵仁淹、宋琳、李向惠、杨佳艳、张传清

Research team:

Jiangquan Yu, Wei Jiang, Keran Shi, Haixia Wang, Renyan Zhao, Lin Song, Xianghui Li, Jiangyan Yang, Chuanqing Zhang

研究实施地点:

Site of Study:

国家(地区):

中国

省(直辖市):

江苏省

市(区县):

扬州

Country/Area:

China

Province:

Jiangsu

City:

Yangzhou
单位 扬州大学附属苏北人民医院
Institution Northern Jiangsu People's Hospital Affiliated to Yangzhou University

预计起止时间:

Planned Duration:

2024/4/1 0:00:00-2025/12/31 0:00:00